Managing Aminotransferase Elevations in Patients with Friedreich Ataxia Treated with Omaveloxolone: A Review and Expert Opinion on Use Considerations
Sign Up to like & getrecommendations! Published in 2025 at "Neurology and Therapy"
DOI: 10.1007/s40120-025-00752-8
Abstract: Omaveloxolone is approved for the treatment of Friedreich ataxia (FA) in patients aged ≥ 16 years and is under clinical development for pediatric patients. In the MOXIe study, alanine and aspartate aminotransferase (ALT and AST)… read more here.
Keywords: aminotransferase elevations; treatment; use considerations; friedreich ataxia ... See more keywords